Search results
Results from the WOW.Com Content Network
Mitragynine is an indole-based alkaloid and is one of the main psychoactive constituents in the Southeast Asian plant Mitragyna speciosa, commonly known as kratom. [4] It is an opioid that is typically consumed as a part of kratom for its pain-relieving and euphoric effects.
In addition to sponsoring scientific research, MAPS organizes continuing medical education (CME) conferences, sponsors and presents lectures and seminars on the state of psychedelic and medical marijuana research, provides psychedelic harm reduction services through the Zendo Project at events such as music festivals and Burning Man, and ...
[9] [11] In October 2018, the Food and Drug Administration granted psilocybin "breakthrough therapy" status for research. [ 6 ] [ 12 ] The drug was granted this status again in November 2019. [ 13 ] Decriminalization advocates have cited research that suggests that the drug is non-addictive and causes a low amount of emergency visits when ...
Mitragyna speciosa is a tropical evergreen tree of the Rubiaceae family (coffee family) native to Southeast Asia. [3] It is indigenous to Cambodia, Thailand, Indonesia, Malaysia, Myanmar, and Papua New Guinea, [4] where its leaves, known as kratom, have been used in herbal medicine since at least the 19th century. [5]
The precursor of the SFCP was a society founded in 1941-1942 as the California Psychoanalytic Society (CPS) with branches in both San Francisco and Los Angeles. The CPS was under the sponsorship and supervision of the Topeka society, which at that time had jurisdiction over all psychoanalytic institutes in the United States west of Kansas. [ 1 ]
Lieutenant Governor Gavin Newsom was the highest-ranking official in the state to endorse the initiative; [106] it was also endorsed by several of the state's major newspapers including the Los Angeles Times, [107] San Francisco Chronicle, [108] San Diego Union-Tribune, [109] Orange County Register, [110] and San Jose Mercury News. [111]
Gladstone Institutes was founded in 1979 as a research and training facility housed at San Francisco General Hospital.Under inaugural president Robert Mahley [4] —a cardiovascular scientist recruited from the National Institutes of Health [5] —the institutes was launched with a $8 million trust from the late commercial real estate developer, J. David Gladstone.
Regarding this, San Francisco attorney Alex Coolman has commented, "It's remarkable that Chidester's parents, and only Chidester's parents, continue to be cited over and over again by the mainstream media in their coverage of the supposed 'controversy' over the risks of Salvia divinorum."